This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2011 Nov 29;9(1):7-8.

doi: 10.1038/nrclinonc.2011.181.

Urological cancer: Time for another rethink on prostate cancer screening

Andrew J Vickers, Hans Lilja

PMID: 22124367
DOI: 10.1038/nrclinonc.2011.181

Urological cancer: Time for another rethink on prostate cancer screening

Andrew J Vickers et al. Nat Rev Clin Oncol. 2011.

. 2011 Nov 29;9(1):7-8.

doi: 10.1038/nrclinonc.2011.181.

Authors

Andrew J Vickers, Hans Lilja

PMID: 22124367
DOI: 10.1038/nrclinonc.2011.181

No abstract available

PubMed Disclaimer

Similar articles

Beyond the PSA test: How to better stratify a patient's risk of prostate cancer.
Lewis R, Hornberger B. Lewis R, et al. JAAPA. 2017 Aug;30(8):51-54. doi: 10.1097/01.JAA.0000521148.78442.d5. JAAPA. 2017. PMID: 28742748
[Prostate cancer screening].
Saksela E. Saksela E. Duodecim. 1997;113(9):871. Duodecim. 1997. PMID: 11466912 Finnish. No abstract available.
Prostate cancer and the PCP: the screening dilemma.
Rosenberg MT, Spring AC, David Crawford E. Rosenberg MT, et al. Int J Clin Pract. 2015 Dec;69(12):1438-47. doi: 10.1111/ijcp.12745. Epub 2015 Oct 13. Int J Clin Pract. 2015. PMID: 26459772 Review. No abstract available.
Screening for prostate cancer: have we resolved the controversy?
Zhu X, Roobol MJ, Schröder FH. Zhu X, et al. Curr Opin Support Palliat Care. 2010 Sep;4(3):121-6. doi: 10.1097/SPC.0b013e32833abc21. Curr Opin Support Palliat Care. 2010. PMID: 20489646 Review.
Detection characteristics in randomized prostate screening.
Schröder FH, Roobol MJ. Schröder FH, et al. Clin Cancer Res. 2004 Sep 1;10(17):5641-2. doi: 10.1158/1078-0432.CCR-04-0278. Clin Cancer Res. 2004. PMID: 15355886 No abstract available.

See all similar articles

Cited by

Limitations of basing screening policies on screening trials: The US Preventive Services Task Force and Prostate Cancer Screening.
Etzioni R, Gulati R, Cooperberg MR, Penson DM, Weiss NS, Thompson IM. Etzioni R, et al. Med Care. 2013 Apr;51(4):295-300. doi: 10.1097/MLR.0b013e31827da979. Med Care. 2013. PMID: 23269114 Free PMC article. Clinical Trial.

References

1. J Clin Oncol. 2011 May 1;29(13):1736-43 - PubMed
1. Cancer. 2010 Oct 15;116(20):4857-65 - PubMed
1. N Engl J Med. 2009 Mar 26;360(13):1320-8 - PubMed
1. Ann Intern Med. 2011 Dec 6;155(11):762-71 - PubMed
1. J Clin Oncol. 2010 Mar 1;28(7):1117-23 - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information